Charles B. Haaser - 15 Aug 2024 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC.

Reporting relationship
VP Finance and CAO
Issuer ticker
N/A
Reported as of
15 Aug 2024
Net transaction value
-$1,096
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Aug 2024, 20:10:36 UTC
Prior SEC filing
16 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Megan N. Gates, attorney-in-fact

Key filing fact

Charles B. Haaser filed Form 4 for YIELD10 BIOSCIENCE, INC. on 19 Aug 2024.

Key facts

  • This page summarizes Charles B. Haaser's Form 4 filing for YIELD10 BIOSCIENCE, INC..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2024, 20:10.

Change

  • Previous filing in this sequence was filed on 16 Feb 2024.
  • Current net transaction value: -$1,096.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

YTEN transaction

Common Stock

Tax liability

Transaction value
$1,096
Shares
-731
Change %
-11%
Price
$1.50
Shares after
5,949
Date
15 Aug 2024
Ownership
Direct
Footnotes
F1, F2
YTEN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,143
Date
15 Aug 2024
Ownership
By 401(k) Plan
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/15/2024.

Footnote F2

Share numbers reflect the 1:24 reverse stock split effected on 5/2/2024.

Footnote F3

Shares acquired as Issuer matching contribution under the Yield10 Bioscience, Inc. 401(k) Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .